Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Point of Care - Sepsis Study

A legfontosabb adatok

Ki végzi
Medical University of Graz
Hol
Ausztria1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
80 fő, tervezett
Kezdés
2026. aug. 13.
Várható befejezés
2028. aug. 31.
A vizsgálat típusa
Megfigyeléses
A vizsgált kezelések
  • Point-of-Care Measurement of Inflammatory Biomarkers
A regiszteradat frissítve
2026. október 6.

Ki vehet részt

Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 4 feltétel megnézéseKevesebb

Ki vehet részt

  • Preterm neonates born at <37+0 weeks of gestation who are admitted to the Division of Neonatology, Department of Pediatrics, Medical University of Graz after birth
  • Written parental informed consent before birth

Ki nem vehet részt

  • Term and preterm neonates who are not admitted to the neonatal care unit
  • No point-of-care measurement of IL-6 and PCT in neonatal blood for infants who do not require blood gas analysis within the first 12 hours of life

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

This pilot study will evaluate whether a rapid point-of-care blood test can help identify early signs of infection and sepsis in preterm infants. The study will include preterm infants born before 37 weeks of pregnancy who are admitted to the neonatal care unit and have a suspected infection.

A teljes eredeti leírásKevesebb

The researchers will measure several substances in the blood that can increase during infection, including interleukin-6 (IL-6), procalcitonin (PCT), C-reactive protein (CRP), and myxovirus resistance protein A (MxA). Results obtained with the point-of-care device will be compared with standard laboratory measurements. The researchers will also study whether measuring IL-6 and PCT during the first 12 hours of life may provide useful information about infection earlier than CRP testing and whether combined MxA and CRP measurements may help distinguish bacterial from viral infections.

This is an observational study and will not change the infants' standard medical care or treatment. Results from the point-of-care device will not be used to make treatment decisions during the study. Blood samples will be collected as part of, or together with, routine blood sampling whenever possible. The study is expected to include approximately 40 preterm infants, with a maximum of 80 infants enrolled.

A vizsgálat csoportja

  • Preterm infants immediately after birth with suspected infection

    Preterm infants born at less than 37 weeks of gestation who are admitted to the neonatal care unit and have a clinical suspicion of infection will be enrolled. Participants will receive standard clinical care according to institutional protocols. As part of the study, inflammatory markers (IL-6, PCT, CRP, and MxA) will be measured using a point-of-care device. Selected measurements will be compared with standard laboratory measurements. Cord blood will be used for IL-6 and PCT measurements at birth. When heel blood is obtained for routine clinical testing, additional point-of-care measurements may be performed during the first 36 hours of life. The point-of-care test results will not be used to guide clinical treatment or patient management. Clinical decisions, including antibiotic treatment and additional diagnostic testing, will be based on standard-of-care assessments.

    Kezelés: Point-of-Care Measurement of Inflammatory Biomarkers

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Diagnostic Accuracy of Inflammatory Parameters for the Diagnosis of Early Onset Neonatal Sepsis and Differentiation Between Viral and Bacterial Infections in Preterm Infants Using a Point-of-care Device - a Pilot Study (POCT Sepsis)
A regiszteradat frissítve
2026. október 6.